GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xintela AB (OSTO:XINT) » Definitions » Interest Received

Xintela AB (OSTO:XINT) Interest Received


View and export this data going back to 2016. Start your Free Trial

What is Xintela AB Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.


Xintela AB (OSTO:XINT) Business Description

Traded in Other Exchanges
Address
Medicon Village, Lund, SWE, 22381
Xintela AB is a biomedical company which utilises its proprietary marker technology XINMARK to develop stem cell-based therapies (XSTEM) for osteoarthritis and antibody-based therapies for Glioblastoma and Tripple-negative breast cancer. XSTEM is also evaluated for the treatment of the severe and deadly lung complication ARDS, which may affect covid-19 patients.